Dr. Marc Grodman has been a leader in driving innovation in new critical areas of diagnostic testing. As the founder of BioReference in 1981, he oversaw unprecedented organic growth while fostering a culture of innovation and entrepreneurial spirit that led to the evolution of a small regional clinical laboratory into one of the largest clinical laboratories in the US with annual sales approaching $1B. He also led GeneDx, a subsidiary of BioReference since 2006 to become world-renowned provider of genetic and genomics testing. BioReference was acquired by OPKO Health in June 2015. Throughout his career, Dr. Grodman has driven innovation in new critical areas of diagnostic testing, bringing clinically relevant information to physicians, as well as formatting data to enhance patient care and scientific advances. Leading a team of premier scientists, Dr. Grodman has created innovative programs in the areas of cancer, genetics and women’s health. Dr. Grodman obtained his BA from the University of Pennsylvania, his MD from Columbia University College of Physicians and Surgeons, attended Harvard University’s Kennedy School of Government, and was a Primary Care Clinical Fellow at Massachusetts General Hospital. Since 1983 he has served as an Assistant Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and serves on the Board of Advisors of the Columbia University Medical Center and was recently elected to the Board of Trustees at the New York Academy of Medicine. Dr. Grodman is the former Chairman and Director at the American Clinical Laboratory Association where he led the industry on numerous critical issues and served as a member of the Executive Committee of the Health Care Leadership Council where he was Chairman of the CEO Patient Safety and Quality Task Force.